Hepzato Kit
Product Images NDC 75833-601

63 FDA label images from Delcath Systems, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 63 technical images submitted to the FDA as part of the official labeling for Hepzato Kit (NDC 75833-601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Delcath Systems, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Hep11 0007 01)

Figure (Hep11 0007 01)
Chemical structure diagram of melphalan hydrochloride, the active ingredient in Hepzato Kit, showing its molecular configuration including functional groups and atomic connections.*
FDA Label Image

Figure (Hep11 0007 02)

Figure (Hep11 0007 02)
Instruction for use cover page for Hepzato Kit, a melphalan injection for hepatic delivery system by Delcath Systems, Inc. The page features the product name and indicates it is an instructional document.*
FDA Label Image

Figure (Hep11 0007 03)

Figure (Hep11 0007 03)
Diagram of the Hepzato Kit assembled system for intra-arterial administration, including labeled components such as double balloon catheter, infusion catheter, hemofiltration cartridges, pressure monitoring lines, and venous return line. It shows the flow path through the system with directional arrows and a human torso outline indicating catheter placement.*
FDA Label Image

Figure (Hep11 0007 04)

Figure (Hep11 0007 04)
Illustration showing components of the Hepzato Kit, including the Delcath Hemofiltration Dual Filter Cartridge, Filter Inflow and Outflow Assemblies, Hemofiltration Circuit with Pump Head, various dilators and introducer sets, double balloon catheter, pressure monitoring lines, CO2 connection line, and Chemofuse infusion catheter. Each component is labeled for intra-arterial administration setup.*
FDA Label Image

Figure (Hep11 0007 05)

Figure (Hep11 0007 05)
Hepzato Kit packaging label showing melphalan hydrochloride injection, powder, lyophilized, for solution. The label indicates it is a kit for intra-arterial use. The labeler is Delcath Systems, Inc. The image shows a white box with green and black text detailing product information.*
FDA Label Image

Figure (Hep11 0007 06)

Figure (Hep11 0007 06)
Hepzato Kit packaging label showing melphalan hydrochloride injection, powder, lyophilized, for solution in a kit dosage form intended for intra-arterial use. The label includes the proprietary name Hepzato Kit and the labeler, Delcath Systems, Inc.*
FDA Label Image

Figure (Hep11 0007 07)

Figure (Hep11 0007 07)
Hepzato Kit packaging label for melphalan hydrochloride injection, powder, lyophilized, for solution. The label indicates it is a human prescription drug provided as a kit for intra-arterial route. The labeler is Delcath Systems, Inc. The packaging background is pink with text and a black acronym 'AN' centered.*
FDA Label Image

Figure (Hep11 0007 08)

Figure (Hep11 0007 08)
The image shows the Hepzato Kit packaging labeled for melphalan hydrochloride injection, powder, lyophilized, for solution. The product is a kit designed for intra-arterial administration. The label specifies it as a human prescription drug by Delcath Systems, Inc. The package appears to be a box with clear branding and product identification.*
FDA Label Image

Figure (Hep11 0007 09)

Figure (Hep11 0007 09)
Hepzato Kit packaging label displaying the proprietary name Hepzato Kit and the active ingredient melphalan hydrochloride injection, powder, lyophilized, for solution. The kit is for intra-arterial use and is labeled by Delcath Systems, Inc. The label features a prominent red square with white text "PH".*
FDA Label Image

Figure (Hep11 0007 10)

Figure (Hep11 0007 10)
Hepzato Kit box packaging containing melphalan hydrochloride injection, powder, lyophilized, for solution for intra-arterial use. The label highlights the proprietary name Hepzato Kit, the generic name melphalan hydrochloride, and indicates it is a human prescription drug. The kit is manufactured by Delcath Systems, Inc.*
FDA Label Image

Figure (Hep11 0007 11)

Figure (Hep11 0007 11)
Hepzato Kit label showing the proprietary name and the IN blue square, indicating intra-arterial use. The label is primarily white and blue with black text, including the generic name melphalan hydrochloride injection, powder, lyophilized, for solution, and the labeler Delcath Systems, Inc.*
FDA Label Image

Figure (Hep11 0007 12)

Figure (Hep11 0007 12)
Hepzato Kit by Delcath Systems, Inc. is an intra-arterial kit containing melphalan hydrochloride injection powder, lyophilized, for solution. The packaging shows the product name prominently, identifies the active ingredient, and includes the labeler and the product NDC 75833-601. The kit format is clearly indicated.*
FDA Label Image

Figure (Hep11 0007 13)

Figure (Hep11 0007 13)
Packaging label for Hepzato Kit containing melphalan hydrochloride injection, powder, lyophilized, for solution. The kit is intended for intra-arterial use and is labeled by Delcath Systems, Inc. The label includes product name, drug form, route of administration, and manufacturer information.*
FDA Label Image

Figure (Hep11 0007 14)

Figure (Hep11 0007 14)
Illustration showing a dual-chamber device or cartridge likely related to the Hepzato Kit, designed for intra-arterial administration. The device features two cylindrical chambers connected by tubing or a structural frame, with visible inlet or outlet ports on top.*
FDA Label Image

Figure (Hep11 0007 15)

Figure (Hep11 0007 15)
Illustration showing two vial-like containers secured in a holder, representing components of a drug kit labeled Hepzato Kit. Each container has a beige and brown cap, with visible liquid or powder contents inside. The image likely depicts the dual vials included in the melphalan hydrochloride injection kit for intra-arterial use by Delcath Systems, Inc.*
FDA Label Image

Figure (Hep11 0007 16)

Figure (Hep11 0007 16)
An instructional diagram depicting a medical infusion setup with labeled components including spikes to heparinized normal saline bags, a pump head, flow probe, filter inflow and bypass line. Tubing connections and flow paths are indicated, demonstrating how the system is arranged for fluid administration.*
FDA Label Image

Figure (Hep11 0007 17)

Figure (Hep11 0007 17)
Illustration diagram of the Hepzato Kit's intra-arterial infusion system setup, showing labeled components such as the Y-adaptor, pump head, flow bubble sensor location, flow probe, filter inflow lines, and connections to heparinized saline bags, with additional labeling indicating usage specifics for Medtronic and Anivia pump systems.*
FDA Label Image

Figure (Hep11 0007 18)

Figure (Hep11 0007 18)
An instructional diagram showing components of the Hepzato Kit, specifically focusing on dual lines labeled 'FILTER INFLOW' connected to valves numbered 5 and 6. The illustration highlights flow paths and includes a detailed inset of the filter inflow mechanism, used for the intra-arterial delivery of melphalan hydrochloride solution.*
FDA Label Image

Figure (Hep11 0007 19)

Figure (Hep11 0007 19)
An instructional diagram showing a dual catheter system with labeled points E, F, 7, and 8. The diagram highlights filter outflow pathways from the two branches labeled 7 and 8, each connecting to boxes labeled 'FILTER OUTFLOW.' It appears to depict fluid flow directions within the device, relevant to an intra-arterial administration system.*
FDA Label Image

Figure (Hep11 0007 20)

Figure (Hep11 0007 20)
An instructional diagram showing tubing connections with labeled filter outflow points. The illustration includes close-up views of tube connectors marked as 7 and 8, and the flow direction indicated by an arrow leading to a filter unit with detailed internal components.*
FDA Label Image

Figure (Hep11 0007 21)

Figure (Hep11 0007 21)
An instructional diagram of the Hepzato Kit, showing the intra-arterial filter system components with labeled sections for filter inflow, filter outflow, and filter bypass. Tubing and clamp valves are indicated to guide fluid flow through or around the filter.*
FDA Label Image

Figure (Hep11 0007 22)

Figure (Hep11 0007 22)
Illustration diagram of the Hepzato Kit's intra-arterial assembly showing tubing connections, including labeled male and female quick connect fittings, filter outflow points on two filters or chambers, and the open end of the tubing. The diagram includes labeled parts E, F, 7, 8, and 9.*
FDA Label Image

Figure (Hep11 0007 23)

Figure (Hep11 0007 23)
Diagram illustrating the Hepzato Kit hemofiltration setup, showing flow paths through hemofiltration cartridges labeled with Delcath. The schematic details filter inflow and outflow, bypass line, various labeled connectors (B, C, D, E, F), and a flow probe for use with a Medtronic pump system. Valves and directional flow are clearly marked for intra-arterial treatment setup.*
FDA Label Image

Figure (Hep11 0007 24)

Figure (Hep11 0007 24)
This illustration diagram depicts the Hepzato Kit tubing setup for intra-arterial administration, highlighting components such as hemofiltration cartridges labeled Delcath, CO2 source with regulator and flow control, pressure relief valve, in-line filter for sterile CO2, flow probe for Medtronic pump system, and various labeled tubing connections including filter inflow and outflow, bypass line, and connection points A, B, C, D, E, and F.*
FDA Label Image

Figure (Hep11 0007 25)

Figure (Hep11 0007 25)
An instructional diagram illustrating a fluid setup for Hepzato Kit intra-arterial administration. It depicts two bags labeled Heparinized Normal Saline connected via spikes to connectors 1 and 2, which merge at a Y-connector (A). Another connector (B) extends from the Y-connector downward, indicating the flow path for saline solution.*
FDA Label Image

Figure (Hep11 0007 26)

Figure (Hep11 0007 26)
An instructional diagram showing a medical tubing setup. It includes an IV spike bag connection, a locking clamp labeled to close off the line, a pump head, and a sterile wrap around part of the tubing. Arrows indicate the direction of flow through the tubes and a numbered clamp for closing the line is highlighted.*
FDA Label Image

Figure (Hep11 0007 27)

Figure (Hep11 0007 27)
Diagram of the Hepzato Kit flow system showing tubing connections, flow path arrows, labeled components including filter inflow, filter bypass, flow probe for Medtronic pump system, and IV spike bags. Key elements are marked with numbers and letters indicating specific parts of the intra-arterial infusion setup.*
FDA Label Image

Figure (Hep11 0007 28)

Figure (Hep11 0007 28)
An instructional diagram showing the flow path through a hemofiltration system labeled 'Delcath' with multiple connectors, arrows indicating fluid direction, flow probe, filter inflow and outflow points, filter bypass, and labeled line points, designed for use with a Medtronic pump system.*
FDA Label Image

Figure (Hep11 0007 29)

Figure (Hep11 0007 29)
Illustration showing part of the Hepzato Kit assembly, including a venous return line with labeled components, a sterile wrap, and a blue sterile pouch. The diagram highlights key parts like the venous return and the sterile packaging for intra-arterial delivery.*
FDA Label Image

Figure (Hep11 0007 30)

Figure (Hep11 0007 30)
An instructional diagram from the Hepzato Kit showing components of the intra-arterial delivery system including female and male quick connect fittings, a bubble trap, filter outflow connections, venous return tubing, and a sterile wrap covering part of the assembly. The diagram labels key parts for assembly and function within the kit.*
FDA Label Image

Figure (Hep11 0007 31)

Figure (Hep11 0007 31)
An instructional diagram showing a hemofiltration circuit with labeled tubing connections, valves, and hemofiltration cartridges. Key components include filter inflow and outflow lines, a venous return line, a bypass line with a filter bypass valve, and a sterile wrap. Arrows and labels indicate flow direction and connection points.*
FDA Label Image

Figure (Hep11 0007 32)

Figure (Hep11 0007 32)
An instructional diagram showing a tubing setup labeled with a pressure monitoring line and a flow probe, designed for use with the Medtronic pump system. The diagram highlights a junction marked "B" and a segment labeled "10" within the tubing configuration.*
FDA Label Image

Figure (Hep11 0007 33)

Figure (Hep11 0007 33)
An instructional diagram showing a medical setup labeled with a Pressure Monitoring Line connected to a Pressure Transducer, a Flow Probe noted as for use with Medtronic Pump System only, and tubing connections identified as A, B, and C. The diagram outlines the arrangement of components for intra-arterial administration associated with the Hepzato Kit.*
FDA Label Image

Figure (Hep11 0007 34)

Figure (Hep11 0007 34)
An anatomical or procedural diagram showing a medical kit setup for intra-arterial use, labeled with ‘FILTER INFLOW,’ ‘FILTER BYPASS,’ and ‘Pressure Monitoring Line.’ The image details tubing lines with connection points marked by letters and numbers, illustrating flow pathways and monitoring components.*
FDA Label Image

Figure (Hep11 0007 35)

Figure (Hep11 0007 35)
An instructional diagram showing a pressure monitoring and bypass system setup associated with a medical kit. Key components labeled include a pressure monitoring line connected to a pressure transducer, filter inflow lines, and a bypass line with a filter bypass valve, highlighting flow direction and connection points.*
FDA Label Image

Figure (Hep11 0007 36)

Figure (Hep11 0007 36)
Hepzato Kit packaging labeled for melphalan hydrochloride injection, powder, lyophilized, for solution. The kit is for intra-arterial use, and the labeler is Delcath Systems, Inc. The front label displays the proprietary name prominently on a mostly white box with some green and black branding accents.*
FDA Label Image

Figure (Hep11 0007 37)

Figure (Hep11 0007 37)
An anatomical illustration showing the internal jugular vein and the placement of a 10F venous return sheath. The diagram highlights the venous return pathway from the liver area through the internal jugular vein toward the heart.*
FDA Label Image

Figure (Hep11 0007 38)

Figure (Hep11 0007 38)
An anatomical illustration showing a catheter insertion into the femoral artery labeled as "5F Introducer for Hepatic Arterial Infusion Catheter." It depicts the vascular route for intra-arterial delivery, likely related to hepatic arterial infusion procedures.*
FDA Label Image

Figure (Hep11 0007 39)

Figure (Hep11 0007 39)
Illustration depicting a human torso focusing on the venous system, highlighting the insertion of an 18F venous sheath into the femoral vein for intra-arterial access, relevant to administration of Hepzato Kit (melphalan hydrochloride injection).*
FDA Label Image

Figure (Hep11 0007 40)

Figure (Hep11 0007 40)
An illustration diagram showing the intra-arterial administration pathway of the Hepzato Kit. It depicts the introducer sheath and 5F infusion catheter inserted through the femoral artery, with arrows indicating the blood flow toward the liver and heart anatomy within the torso outline.*
FDA Label Image

Figure (Hep11 0007 41)

Figure (Hep11 0007 41)
The image shows a Hepzato Kit packaging label for melphalan hydrochloride injection, powder, lyophilized, for solution. The label indicates the product is a kit intended for intra-arterial administration. The labeler is Delcath Systems, Inc., with product NDC 75833-601. The label includes boxes marked PF, DD, and IR, likely representing kit components or preparation steps.*
FDA Label Image

Figure (Hep11 0007 42)

Figure (Hep11 0007 42)
Hepzato Kit includes two labeled vials, one with a green cap marked 'IR' and the other with an orange cap marked 'PF.' The product is melphalan hydrochloride injection, powder, lyophilized, for solution in a kit form, intended for intra-arterial use. The labeler is Delcath Systems, Inc.*
FDA Label Image

Figure (Hep11 0007 43)

Figure (Hep11 0007 43)
Illustration depicting a double balloon catheter setup connected to fluid bags labeled 1 and 2, with points marked A, B, and numbered connectors including 3, showing flow direction and connection details for intra-arterial administration.*
FDA Label Image

Figure (Hep11 0007 44)

Figure (Hep11 0007 44)
Diagram of the Hepzato Kit system showing the intra-arterial melphalan hydrochloride injection setup including a double balloon catheter line, hemofiltration cartridges labeled Delcath, pressure monitoring lines with transducers, flow probe, venous return line with bubble trap, and various catheters and sheaths. The diagram features labeled connectors and flow directions for use with a Medtronic pump system.*
FDA Label Image

Figure (Hep11 0007 45)

Figure (Hep11 0007 45)
Hepzato Kit packaging label showing the product name Hepzato Kit with the generic designation melphalan hydrochloride injection, powder, lyophilized, for solution. The kit is intended for intra-arterial use. The label indicates it is manufactured by Delcath Systems, Inc., with product NDC 75833-601. The packaging includes color-coded sections marked IR, PF, and AN.*
FDA Label Image

Figure (Hep11 0007 46)

Figure (Hep11 0007 46)
An angiographic image showing a balloon indentation labeled as an "Acorn" shape, illustrating a specific vascular or catheter balloon morphology. The image includes an arrow pointing to the balloon indentation area.*
FDA Label Image

Figure (Hep11 0007 47)

Figure (Hep11 0007 47)
A medical imaging scan showing an intra-arterial contrast flow highlighting the branching blood vessels in a patient's organ. The image depicts the vascular structure with a catheter inserted, commonly used for guiding intra-arterial drug delivery procedures.*
FDA Label Image

Figure (Hep11 0007 48)

Figure (Hep11 0007 48)
Hepzato Kit by Delcath Systems, Inc. is labeled for melphalan hydrochloride injection, powder, lyophilized, for solution. The label indicates it is a kit dosage form intended for intra-arterial administration. The packaging displays the product name and highlights two color-coded sections labeled 'AN' and 'PF'.*
FDA Label Image

Figure (Hep11 0007 49)

Figure (Hep11 0007 49)
Diagram illustrating the assembled Hepzato Kit system, including components such as hemofiltration cartridges, double balloon catheter, infusion and venous return catheters, pressure transducers, flow and pressure monitoring lines, a bubble trap, and associated tubing. The diagram highlights pathways for blood flow, venous return, and infusion, with detailed insets showing catheter placement in the vascular system.*
FDA Label Image

Figure (Hep11 0007 50)

Figure (Hep11 0007 50)
Hepzato Kit packaging label shows the product name Hepzato Kit with melphalan hydrochloride injection, powder, lyophilized, for solution as the generic name. The dosage form is a kit intended for intra-arterial use. The labeler is Delcath Systems, Inc. The packaging is predominantly yellow and includes a logo with the initials IR and DD.*
FDA Label Image

Figure (Hep11 0007 51)

Figure (Hep11 0007 51)
An illustration showing components of the Hepzato Kit including two intravenous bags labeled as 'HEPZATO drug solution bag provided by pharmacy' and 'Normal Saline bag for priming and flushing the system,' connected by tubing to a 48-inch injection line and a syringe. The diagram depicts the fluid pathway for intra-arterial administration.*
FDA Label Image

Figure (Hep11 0007 52)

Figure (Hep11 0007 52)
An instructional diagram showing three syringes labeled for use with contrast, NTG (nitroglycerin), and normal saline. The syringes are connected to a system with stopcocks, with instructions to use normal saline to flush between contrast injections, perform vessel spasm checks, and administer intra-arterial NTG. Recommendations include using two stopcocks, keeping the NTG syringe on the back table, replacing the saline syringe when NTG is needed, and using saline flush to reduce inadvertent NTG administration.*
FDA Label Image

Figure (Hep11 0007 53)

Figure (Hep11 0007 53)
An instructional diagram showing the components and setup of the Hepzato Kit for intra-arterial use. It labels syringes with Normal Saline for flushing between contrast injections, bags for Hepzato drug solution and normal saline for system priming and flushing, and a 48-inch injection line connecting the components.*
FDA Label Image

Figure (Hep11 0007 54)

Figure (Hep11 0007 54)
Hepzato Kit packaging displaying text in two labeled sections: a green square with the letters 'IR' and an orange rectangle with the letters 'PF'. The product is melphalan hydrochloride injection, powder, lyophilized, for solution, labeled by Delcath Systems, Inc., intended for intra-arterial use.*
FDA Label Image

Figure (Hep11 0007 55)

Figure (Hep11 0007 55)
Diagram of the Hepzato Kit assembled system showing components and flow path for intra-arterial melphalan hydrochloride administration. Key features include double balloon catheter, hemofiltration cartridges labeled Delcath, pressure monitoring lines, filters, flow probe, and venous return sheaths. The illustration also highlights catheter lines and fluid bags used in the system.*
FDA Label Image

Figure (Hep11 0007 56)

Figure (Hep11 0007 56)
Hepzato Kit by Delcath Systems, Inc., labeled as melphalan hydrochloride injection, powder, lyophilized, for solution. The packaging is a white box with green accents and text, and prominently displays the product name Hepzato Kit along with a partial view of related regulatory and product information labels. The kit is intended for intra-arterial administration.*
FDA Label Image

Figure (Hep11 0007 57)

Figure (Hep11 0007 57)
Hepzato Kit packaging showing a box with branding in purple and white colors. The product is melphalan hydrochloride injection, powder, lyophilized, for solution in intra-arterial kit dosage form, labeled by Delcath Systems, Inc. The label includes the proprietary name Hepzato Kit with the company logo and NDC 75833-601.*
FDA Label Image

Figure (Hep11 0007 58)

Figure (Hep11 0007 58)
A detailed flowchart diagram illustrating the procedural steps involved in using the Hepzato Kit for melphalan hydrochloride intra-arterial infusion. It outlines roles and activities for the anesthesiologist, radiologist, oncologist, perfusionist, registered nurse, and intensive care unit, including patient preparation, catheter placement, drug delivery, perfusion management, filtration, and post-procedure care. Color-coded sections represent different roles and tasks within the interventional radiology suite and intensive care unit.*
FDA Label Image

Figure (Hep11 0007 59)

Figure (Hep11 0007 59)
The image shows a Hepzato Kit packaging label. It contains melphalan hydrochloride injection, powder, lyophilized, for solution in a kit dosage form. The label highlights the intra-arterial route of administration and indicates the product is a human prescription drug. The labeler is Delcath Systems, Inc.*
FDA Label Image

Principal Display Panel (Kit Label)

Principal Display Panel (Kit Label)
Label for Hepzato Kit (melphalan) for Injection/Hepatic Delivery System by Delcath Systems, Inc. Includes product reference number 601002, placeholders for expiration date and lot number, and details contents including a hepatic delivery system catheter and melphalan vials. Storage and usage cautions are noted along with barcodes and QR codes for tracking.*
FDA Label Image

Principal Display Panel – 50 mg Vial Label (Hep11 0007 61)

Principal Display Panel – 50 mg Vial Label (Hep11 0007 61)
Hepzato Kit melphalan hydrochloride injection, powder, lyophilized, for solution, 50 mg per vial, single-dose vial. Label shows that it is a hazardous drug for intra-arterial infusion only with the Delcath Hepatic Delivery System. Manufactured for Delcath Systems, Inc. by Mylan Institutional LLC in Italy. Storage instructions and reconstitution requirements are included.*
FDA Label Image

Principal Display Panel – 10 mL Diluent Vial Label (Hep11 0007 62)

Principal Display Panel – 10 mL Diluent Vial Label (Hep11 0007 62)
Label of a single-dose vial of sterile diluent for Hepzato injection (melphalan). The label specifies that the vial is for drug diluent use only and contains sodium citrate, propylene glycol, ethanol, and water for injection. Manufactured for Delcath Systems, Inc., Queensbury, NY, and made in Italy. The label includes storage instructions and barcode.*
FDA Label Image

Principal Display Panel (0.9 g/250 mL Container Label)

Principal Display Panel (0.9 g/250 mL Container Label)
Label for 0.9% Sodium Chloride Injection USP in a 250 mL container by B. Braun Medical Inc. This sterile, nonpyrogenic single-dose intravenous injection solution is adjusted to pH 5.6 and contains sodium chloride and water for injection. The label includes storage instructions, warnings, and manufacturer contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.